AAA
12
1
2
4
Key Insights
Highlights
Success Rate
57% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
25.0%
3 terminated out of 12 trials
57.1%
-29.4% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft
First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA)
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Central Blood Pressure and Variability Evaluation
Endurant Evo International Clinical Trial
Endurant Evo US Clinical Trial
E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms
Iliac Branch Device Movement During Cardiac Cycle (IBD-dynamics)
NHS AAA Screening Programme Data Linkage With HES and ONS Datasets
Abdominal Aortic Aneurysm Patients Remain at Risk for Delirium on the Surgical Ward After Intensive Care Unit Dismissal
Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)